Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Payables (2016 - 2025)

Medicure has reported Payables over the past 17 years, most recently at $2.1 million for Q4 2025.

  • For Q4 2025, Payables rose 697.79% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.1 million, up 697.79%, while the annual FY2025 figure was $2.1 million, 697.79% up from the prior year.
  • Payables for Q4 2025 was $2.1 million at Medicure, down from $5.7 million in the prior quarter.
  • Over five years, Payables peaked at $5.7 million in Q3 2025 and troughed at -$826491.0 in Q3 2023.
  • A 5-year average of $375032.1 and a median of -$26000.4 in 2024 define the central range for Payables.
  • Biggest five-year swings in Payables: plummeted 384.94% in 2022 and later surged 5058.73% in 2025.
  • Year by year, Payables stood at $317334.4 in 2021, then skyrocketed by 31.86% to $418447.3 in 2022, then crashed by 141.43% to -$173350.4 in 2023, then tumbled by 104.0% to -$353629.5 in 2024, then skyrocketed by 697.79% to $2.1 million in 2025.
  • Business Quant data shows Payables for MCUJF at $2.1 million in Q4 2025, $5.7 million in Q3 2025, and $444574.9 in Q2 2025.